Shiyu Capital logo

Shiyu Capital

Asia, Beijing, China, Beijing

Description

Shiyu Capital operates as an equity investment and asset management institution.

Investor Profile

Shiyu Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D, Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Health Care, Medical, Therapeutics.

Stage Focus

  • Series B (50%)
  • Series D (25%)
  • Series C (25%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Medical
  • Therapeutics
  • Biotechnology
  • Health Diagnostics
  • Hospital
  • Wellness
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shiyu Capital frequently co-invest with?

HF
Asia, Beijing, China, Beijing
Co-Investments: 1
Cowin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
HLC Equity
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
ZHENGQI FINANCIAL
Asia, Anhui, China, Hefei
Co-Investments: 1
General Atlantic
North America, New York, United States, New York
Co-Investments: 1
Highlight Capital
Asia, Jiangsu, China, Nanjin
Co-Investments: 1
Ares Management
North America, Illinois, United States, Chicago
Co-Investments: 1
CPE
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Shiyu Capital?

Biotheus

Zhuhai, Guangdong, China

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.

BiotechnologyHealth Care
Series DMar 2, 2021
Amount Raised: $100,000,000
WuXi Diagnostics

Shanghai, Shanghai, China

WuXi Diagnostics is the first enabling platform company in China to practice integrated diagnosis.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series BFeb 23, 2021
Amount Raised: $150,000,000
CARsgen Therapeutics

Shanghai, Shanghai, China

CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor

Health DiagnosticsMedicalTherapeutics
Series CNov 2, 2020
Amount Raised: $186,000,000
PhiSkin

Shanghai, Shanghai, China

PhiSkin is a minimal invasive medical aesthetic clinics chain in China.

Health CareHospitalMedicalTherapeuticsWellness
Series BJun 6, 2017
Amount Raised: $17,656,237